The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples